Corpus Intelligence IC Memo — CHILDRENS HEALTH CARE 2026-04-26 03:43 UTC
IC Memo — CHILDRENS HEALTH CARE
Investment Committee Memorandum | MN | 400 beds | Grade C | EBITDA uplift $71.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CHILDRENS HEALTH CARE

CCN 243302 | HENNEPIN, MN | 400 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

CHILDRENS HEALTH CARE is a 400-bed safety-net/medicaid heavy in HENNEPIN, MN with $965.5M in net patient revenue and a -3.1% operating margin. The hospital serves a payer mix of 0.1% Medicare, 60.4% Medicaid, and 39.5% commercial.

Thesis: Undervalued. Our ML models identify $71.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.1% to 4.2% (+736bps).

Net Revenue HCRIS$965.5M
Current EBITDA COMPUTED$-30.3M
Operating Margin COMPUTED-3.1%
Occupancy HCRIS72.7%
Revenue / Bed COMPUTED$2.4M
Net-to-Gross HCRIS46.2%
Distress Probability ML56.7%

2. Market Context & Competitive Position

141
MN Hospitals
-3.6%
State Median Margin
12
Comparable Hospitals

MN has 141 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of -3.1% places it above the state median. Among 12 size-comparable peers (200-800 beds), the median margin is -8.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (200-800), prioritizing same-state peers. 12 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CHILDRENS HEALTH CARE (Target)MN400$965.5M-3.1%
UNIVERSITY OF MINNESOTA MEDICAMN634$1.84B-18.1%
ABBOTT NORTHWESTERN HOSPITALMN586$1.24B-26.9%
HENNEPIN COUNTY MEDICAL CENTERMN335$1.19B-11.2%
ST. CLOUD HOSPITALMN458$943.6M-1.7%
REGIONS HOSPITALMN423$862.7M-7.6%
MERCY HOSPITALMN464$783.1M-7.3%
UNITED HOSPITALMN362$762.9M-10.0%
PARK NICOLLET METHODIST HOSPITMN353$741.7M3.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $71.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$20.3M+210bp18mo
Cost to Collect4.5%2.5%$19.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$19.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$11.7M+122bp9mo
Clean Claim Rate88.0%96.0%$618K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$20.3M
Cost to Collect
$19.3M
Denial Rate Reduction
$19.1M
A/R Days Reduction
$11.7M
Clean Claim Rate
$618K
Total EBITDA Uplift$71.1M
Current EBITDA$-30.3M
+ RCM Uplift+$71.1M
Pro Forma EBITDA$40.8M
Current Margin-3.1%
Pro Forma Margin4.2%
WC Released (1x)$37.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-46.6M$510.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-46.6M$546.9M0.00x-100.0%
Bull Case9.0x11.0x$-41.9M$766.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-41.9M$823.6M0.00x-100.0%
Bear Case11.0x10.0x$-51.3M$170.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-51.3M$171.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumElevated Medicaid exposure (60.4%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
HighElevated distress probabilityModel estimates 56.7% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 12 hospitals with 200-800 beds
  • Same-state prioritization (n=13)
  • Comp margins: P25=-12.9% / P50=-8.4% / P75=-3.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.